MO - Altria Group, Inc.
| Previous Close | 54.18 |
| Open | 54.41 |
| Bid | 0.00 x 1200 |
| Ask | 0.00 x 800 |
| Day's Range | 52.73 - 54.48 |
| 52 Week Range | 52.73 - 74.38 |
| Volume | 10,323,289 |
| Avg. Volume | 8,747,335 |
| Market Cap | 100.266B |
| Beta (3Y Monthly) | -0.14 |
| PE Ratio (TTM) | 9.48 |
| EPS (TTM) | 5.63 |
| Earnings Date | Jan 30, 2019 - Feb 4, 2019 |
| Forward Dividend & Yield | 3.20 (5.91%) |
| Ex-Dividend Date | 2018-09-13 |
| 1y Target Est | 65.09 |
- InvestorPlace•12 hours ago
4 Reasons Why Aphria Stock Could Be an M&A Target Next
Despite broader market turmoil, the cannabis sector is starting to heat up again thanks to M&A activity. First it was Canopy Growth (NYSE:CGC), then Cronos (NASDAQ:CRON), and I think the next target is going to be Aphria (NYSE:APHA) stock. Now, everyone is again bidding up pot stocks in an attempt to find the next M&A target, which leads us to Aphria.
- Zacks•8 hours ago
Cronos Group (CRON) Soars on C$2.4B Investment from Altria
Cronos Group (CRON) receives a significant boost with C$2.4-billion equity investment from tobacco giant Altria Group.
Zacks•16 hours agoCronos-Altria Deal Boost Marijuana ETF: Will This Continue?
Altria investment in Canadian cannabis producer Cronos sparked a rally in the broad cannabis sector and the its ETF. Will the trend continue?
- InvestorPlace•17 hours ago
Monday’s Vital Data: Cronos Group, Tesla and American Airlines
- Motley Fool•12 hours ago
Investing Through Impending Recessions: A Guide
The storm clouds are getting darker -- high time for investors to think about buying a few more stocks.
- Barrons.com•13 hours ago
Marijuana Producer Cronos Found the Right Partner in Marlboro Maker Altria, Analyst Says
Cronos is building a portfolio of the cannabis extracts known as cannabinoids, which it could mass produce with help from Altria, the Philip Morris parent and maker of the dominant cigarette brand Marlboro.
Investopedia•4 days agoWhich Company Is Behind Popular E-Cigarette, JUUL?
- Motley Fool•15 hours ago
Who's Next After Canopy Growth's and Cronos Group's Huge Deals?
More big cannabis industry deals could be on the way. But which marijuana producers are the top candidates to partner with major companies outside of the industry?
- Bloomberg•16 hours ago
Pot May Be Next for Tobacco Farmers Already Turning to Hemp
Altria Group Inc., the U.S. maker of Marlboro cigarettes, made a $1.8 billion investment in Cronos Group Inc. on Friday amid pressure to find new growth avenues as U.S. smoking rates decline. The partnership, which includes the option for Altria to take majority control in the future, may see the firm’s U.S. tobacco suppliers switch to cannabis if the drug is legalized, said Mike Gorenstein, chief executive officer of Toronto-based Cronos. “It’s certainly helpful that Altria already has a relationship with local contract farmers,” Gorenstein said in a phone interview Friday.
- CNBC•18 hours ago
Wall Street's top pot analyst loves Cronos deal for Altria: 'Unique entry into cannabis'
Wall Street's top marijuana analyst likes Marlboro maker Altria's $1.8 billion investment in Canadian pot company Cronos Group, telling clients the move represents a "unique entry into cannabis."
- MarketWatch•2 days ago
Cronos CEO: $1.8 billion from Big Tobacco is just a beginning for cannabis industry
Marijuana companies and legacy businesses are playing a proverbial game of speed dating right now, according to a top cannabis executive who managed to land an attractive partner.
- MarketWatch•2 days ago
Cannabis stock Cronos soars 24% as Altria takes major stake, sparking sector rally
Shares of Canada’s Cronos Corp. rocketed more than 24% Friday, after Altria Group Inc. agreed to take a major stake in the company and become its exclusive partner in the cannabis sector as new markets for medical and recreational weed open around the world.
- GlobeNewswire•19 hours ago
New Research Coverage Highlights Skyworks Solutions, Virtus Investment Partners, Altria Group, Gilead Sciences, Arthur J. Gallagher, and BP p.l.c — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Dec. 10, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
- ACCESSWIRE•19 hours ago
Today's Research Reports on Trending Tickers: Moderna and Altria
NEW YORK, NY / ACCESSWIRE / December 10, 2018 / Although Moderna sank in its first day of trading, the stock was still the biggest IPO in the biotech arena ever last week. Shares of Altria Group also hit red territory despite announcing it would take a whopping stake in Canadian marijuana company Cronos Group. Moderna, Inc. shares were down a little over 19% on Friday with nearly 13 million shares traded.
- Market Exclusive•yesterday
Tobacco Giant Altria Grabs Share Of Cannabis Market With $2.4 Billion Investment In Cronos
Tobacco giant Altria Group Inc (NYSE:MO) has made its move in the cannabis industry. The Marlboro cigarettes maker has confirmed an investment deal of $2.4 billion with Canadian cannabis company Cronos Group Inc (NASDAQ:CRON). The deal will give Altria a 45% ownership stake with an additional option of another 55% over the next five years. Speaking […] The post Tobacco Giant Altria Grabs Share Of Cannabis Market With $2.4 Billion Investment In Cronos appeared first on Market Exclusive.
- Motley Fool•2 days ago
Better Marijuana Stock: Cronos Group vs. GW Pharmaceuticals
Which stock wins in a matchup between this top Canadian marijuana grower and the biggest cannabis-focused biotech?
- Insider Monkey•2 days ago
Is Altria Group Inc (MO) Going to Burn These Hedge Funds?
Reputable billionaire investors such as Nelson Peltz and David Tepper generate exorbitant profits for their wealthy accredited investors (a minimum of $1 million in investable assets would be required to invest in a hedge fund and most successful hedge funds won’t accept your savings unless you commit at least $5 million) by pinpointing winning small-cap […]
Motley Fool•2 days agoWhy Altria Group Stock Lost 16% Last Month
Shares of the Marlboro maker slipped on a pair of announcements from the Food and Drug Administration.
- TheStreet.com•2 days ago
Is It Too Late to Jump on Board Altria Stock?
Take "Operation Barbarossa" for example. Not to mention that I drove past the firm's plant in Richmond, Virginia the other day and that I like chewing tobacco, though not the powdery snuff sold through Altria's brands. Then a friend who I think of as a gifted trader, we'll call her Laura, mentioned in passing that she had taken down a long position in Altria.
- TheStreet.com•2 days ago
Cannabis Firm Cronos Soars 21.7% on $1.8B Investment From Marlboro Maker Altria
lit up Friday after the company announced that Altria Group Inc. , the maker of Marlboro cigarettes, made a $1.8 billion investment in the Canadian cannabis company in exchange for a 45% stake. Altria also has options that if fully exercised would result in an additional $1.05 billion in proceeds for Cronos in exchange for an extra 10% stake for Altria.
- Motley Fool•3 days ago
Altria Buys a $1.8 Billion Stake in Cronos Group: 3 Things You Need to Know About the Monster Deal
A Big Tobacco company makes a big bet on marijuana. Here's what it means.
- InvestorPlace•3 days ago
5 Must-See Stock Charts for Monday: LULU, AVGO, ULTA Earnings
A top and bottom line earnings beat and in-line outlook weren’t enough to boost Lululemon Athletica (NASDAQ:LULU). Ulta Beauty (NYSE:ULTA) has a similar story, with shares down more than 11% post-earnings. Twitter (NYSE:TWTR) was one of the few bright spots on the day.
- InvestorPlace•4 days ago
Why Cronos (CRON) Stock Is Skyrocketing Today
An announcement from Cronos (NASDAQ:CRON) confirms that Altria is planning to make a C$2.40 billion equity investment into the marijuana company. This money will have MO buying up shares of Cronos stock for C$16.25 each. The deal will have Altria owning 45% of Cronos stock once it is complete.
- CNBC Videos•3 days ago
What makes Cronos a better takeover target than Alpha? On...
A tale of two pot stocks, in a wild week for cannabis. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Steve Grasso, Karen Finerman and Dan Nathan.
